from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2516c/-

LFCtreatmentdescriptionclass of inhibitor

1.550

Amikacinug/mL Amikacintranslation

1.370

Cap5-10ug/mL Capreomycintranslation

2.853

Rox10-50 ug/mL Roxithromycintranslation

0.515

SM2-5 ug/mL Streptomycintranslation

1.444

Tet5-10 ug/mL Tetracyclinetranslation

-0.442

Rif0.2-5ug/mL Rifampicintranscription

-0.516

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.092

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.089

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.700

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.191

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.495

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.977

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.137

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.353

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.070

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.579

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.671

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.297

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.226

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.731

KCN5-20 ug/mL Potassium cyaniderespiration

-0.925

NaN30.2-2 mM Sodium aziderespiration

-0.001

Nigericin50 uM Nigericinrespiration

0.383

TRC10-150 ug/mL Triclosanrespiration

0.207

TRZ10-25 ug/mL Thioridazinerespiration

2.062

Valinomycin0.5-10 uM Valinomycinrespiration

-0.035

ZnSO42 mM ZnSO4respiration

0.087

menadione6-10 ug/mL Menadionerespiration

-0.092

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.646

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.511

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.764

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.055

NRP_1Non-replicating persistence stage 1dosRassociated

-0.711

Amp0.2mg/mL AmpicillincellWall

-0.820

Cephalexin20-100 ug/mL CephalexincellWall

-0.552

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.085

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.545

EMB10-20 ug/mL EthambutolcellWall

-0.152

Eta12-40 ug/mL EthionamidecellWall

-0.765

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.543

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.552

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.572

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.359

BZA0.12 mg/mL BenzamidearomaticAmides

0.235

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.111

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.330

H2O24 mM hydrogen peroxideDNAdamaging

-0.481

Levo10 ug/mL LevofloxacinDNAdamaging

-0.289

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.356

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.632

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.065

UVUV-irradiationDNAdamaging

0.227

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.486

Antimycin12.5-50 ug/mL Antimycin A?

-0.516

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.863

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.862

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.802

PA8240.2-2 ug/mL PA-824?

0.878

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.174

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.389

Verapamil50 uM Verapamil?

-0.532

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.622

methoxatin10-20 ug/mL Methoxatin?